|
BR1321a : Breast cancer tissue array with lymph node metastasis (LN+) and non-lymph node metastatic (LN-), including pathology grade, TNM, clinical stage and IHC results (ER/PR/HER2/Ki-67),120 cases/132 cores, replacing BR1321
Description
| Microarray Panel |
Breast invasive carcinoma of no special type tissue microarray with adjacent normal tissue, containing 60 cases of lymph node metastasis (LN+), 50 No lymph node metastatic (LN-), 1 normal breast tissue, plus 9 adjacent normal tissue, triplicate cores of lymph node positive (LN+) from 1-3 cases, single core of the last 57 cases of lymph node positive (LN+), triplicate cores of lymph node positive (LN-) from 1-3 cases, single core of the last 47 cases of lymph node positive (LN-), single core normal and adjacnet normal bresat tissue |
| Cores |
132 |
|
| Cases |
120 |
| Row number |
12 |
| Column number |
11 |
| Core Diameter (mm) |
1 |
| Thickness (µm) |
5 |
| Tissue Array Type |
FFPE |
| Species |
Human |
| Applications |
54 |
| Notes |
1. TMA slides were sectioned and stored at 4°C and may not be fresh cut, but still suitable for IHC. Please request fresh cut if experiment involves phospho-specific antibodies, RNA studies, FISH or ISH, etc. A minimum of 3 slides per TMA must be purchased to cover the cost of trimming for fresh sectioning.
2. Most TMA slides were not coated with an extra layer of paraffin (tissue cores can be easily seen on the glass). To prevent tissue detachment during antigen retrieval, unbaked slides must be baked for at least 30 to 120 minutes at 60°C. before putting into xylene for de-paraffinization. Baked slides were sent out baked for 2 hours.In the following specsheet,“*” means invalid core; “-” means no applicable or negative in IHC markers. |
Mouseover and click individual cores to view high resolution images.
Specification Sheet (Sortable), tissue IDs are available in exported Excel files.
Find overlapping cases with this tissue array:
- Product Code: BR1321a
- Availability: In Stock
|
Tags:
With normal control,
Stage (TNM),
Triplicate cores per case,
With normal control (),
Single core per case
- Malignant tumor,
- Malignant tumor (stage I),
- Malignant tumor (stage IIA),
- Malignant tumor (stage IIB),
- Malignant tumor (stage IIIA),
- Malignant tumor (stage IIIB),
- Malignant tumor (stage IV),
- NAT,
- Normal tissue